Detailed Result for NCT01291836
NCT ID: | NCT01291836 |
---|---|
NLM Download Date Description: | N/A |
Study First Submitted Date: | 2011-02-07 |
Last Update Submitted Date: | 2017-08-05 |
Last Update Submitted Date: | 2017-08-05 |
Result First Submitted Date: | 2016-01-05 |
Disposition First Submitted Date: | N/A |
Start Month Year: | December 2010 |
Start Date: | 2010-12-31 |
Start Date Type: | N/A |
Verification Month Year: | August 2017 |
Verification Date: | 2017-08-31 |
Completion Month Year: | June 2015 |
Completion Date: | 2015-06-30 |
Completion Date Type: | Actual |
Primary Completion Month Year: | October 2013 |
Primary Completion Date: | 2013-10-31 |
Primary Completion Date Type: | Actual |
Study first Submitted QC Date: | 2011-02-08 |
Study first posted Date: | 2011-02-09 |
Result first Submitted QC Date: | 2017-08-05 |
Result First Posted Date: | 2018-02-19 |
Disposition First Submitted QC Date: | N/A |
Disposition First Posted Date: | N/A |
Last Updated Submitted QC Date: | 2017-08-05 |
Last Updated Posted Date: | 2018-02-19 |
Target Duration: | N/A |
Study Type: | Observational |
Acronym: | AKINESIS |
Baseline Population: | ED presentation with symptoms of Heart Failure. |
Brief Title: | Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Symptomatic Heart Failure Study |
Official Title: | Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin (N-GAL) Evaluation of Symptomatic Heart Failure Study (AKINESIS) |
Overall Status: | Completed |
Last Known Status: | N/A |
Phase: | N/A |
Enrollment: | 930 |
Enrollment Type: | Actual |
Source: | Alere San Diego |
Limitation and Caveats: | N/A |
Number of Arms: | N/A |
Number of Groups: | N/A |
Why Stopped: | N/A |
Has Expanded Access: | N/A |
Expanded Access Type Individual: | N/A |
Expanded Access Type Intermediate: | N/A |
Expanded Access Type Treatment: | N/A |
Has DMC: | true |
Is it FDA Regulated Drug: | N/A |
Is it FDA Regulated Device: | N/A |
Is it Unapproved Device: | N/A |
Is PPSD: | N/A |
Is US Export: | N/A |
Is Biospec Retention: | Samples Without DNA |
Biospec Description: | Urine Samples, Plasma Samples |
Plan to Share IPD: | N/A |
Plan to Share IPD Description: | N/A |
IPD Time Frame: | N/A |
IPD Access Criteria: | N/A |
IPD URL: | N/A |